TOP 100 MEDICAL SITES
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HealthPartners saves money with e-records HealthPartners is providing some proof for health reform advocates who say that electronic medical records can save health providers money. feeds.bizjournals.com |
ImmunoCellular: Roche Pact Validates Pipeline Potential Mike Havrilla submits:Live from New York . . . a deal in the bio-med space. On my first day at the Rodman & Renshaw Healthcare conference, a deal was announced before the market open for a company in the cancer immunotherapy space that I have previously featured at BioMedReports.com. ImmunoCellular Therapeutics, Ltd. (IMUC.OB) announced today that it has entered a research and license option agreement for its ICT-69 monoclonal antibody (mAb) with Roche Group (RHHBY.PK). Under the terms of the agreement, IMUC will license to Roche the rights to investigate the potential of ICT-69 in the diagnosis and treatment of multiple myeloma and ovarian cancer for an upfront payment. Complete Story » seekingalpha.com |
Insurers Stand Against Committee's Plan The insurance industry said it opposed the Senate Finance Committee's health bill, after ratcheting up concerns that the measure would raise insurance costs. online.wsj.com |
Vaccine Shown Safe in Pregnant Women The NIH said initial results of a small study of the H1N1 vaccine in pregnant women showed the vaccine was effective and appeared to be safe. online.wsj.com |
Diabetes Meter Mates With a PC Walt Mossberg calls the Contour USB a computer-savvy device that can help diabetics track health trends. online.wsj.com |